This study investigates the use of exercise as a treatment for vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia (ALL). Peripheral neuropathy is a condition where nerves are damaged, causing weakness, numbness, and pain, typically in the hands and feet. This study aims to see if exercise can be a feasible and acceptable way to manage these symptoms.
Participants in the study will engage in a structured exercise program. The study will monitor how well participants can follow the exercise routine and how acceptable they find it as part of their treatment plan.
- Who can participate: This study is for children aged 3 to 18 years diagnosed with acute lymphoblastic leukemia who are experiencing peripheral neuropathy due to vincristine treatment.
- Study details: Participants will take part in a structured exercise program designed to help manage symptoms of peripheral neuropathy. No placebo will be used in this study.
How understandable was the trial content above?
Hard to understand
Easy to understand
